Sayed Galal Hospital and Shoubra General Hospital
Cairo, Egypt
NCT Number: NCT04656067
Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate, Pre-operative Administration.
Looking for future studies?
Notify Me20 year–40 year
Female
Interventional
Phase 1 / Phase 2
Cairo, Egypt
Caesarean Delivery commonly referred to as caesarean section and occasionally caesarean birth is defined as the delivery of a foetus(es) through surgical incisions made through the anterior abdominal wall (technically referred to as laparotomy) and the anterior uterine wall (technically denoted to as hysterotomy).
Obstetric Hemorrhage (Intra operative OR post operative bleeding)is still the major cause of maternal morbidity and mortality worldwide contributing to nearly 25% of direct maternal deaths. And accounts for 50% of maternal mortality in low-income countries.
So many Strategies reducing the intraoperative blood loss or post operative blood loss could be helpful in decreasing the risks of blood transfusion and the postoperative maternal morbidity.
So these Medications are such as Oxytocin, Carbetocin, Misoprostol, Prostaglandin F2 alpha, methylergonovine, Tranexamic acid and Etamsylate . have been tried before to control bleeding during and after Cesarean Section.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Is to compare blood loss during elective cesarean section intraoperative and postoperative in cases receiving Oxytocin versus Tranexamic acid and Ethamsylate
Other names: Syntocinon , Kapron, Dicynon
Time frame: First 2 hours after C-Section
Outcome of the study will be measured in terms of assessment of Hemoglobin level and Hematocrit level pre and post operatively.
Time frame: first 24 hours after C-Section
Outcome of the study will be measured in terms of assessment of Hemoglobin level and Hematocrit level post operatively.
Egymedicalpedia
Industry
Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate to Reduce Blood Loss Intraoperative and Post Operative During Elective Cesarean Section
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03249038
Blood Loss, Blood Loss, Postoperative
View Trial DetailsNCT06049160
Blood Loss, Postoperative, Blood Loss, Surgical
Cairo, Egypt
View Trial DetailsNCT05273632
Blood Loss, Postoperative, Blood Loss, Surgical
Cairo, Egypt
View Trial DetailsNCT07712510
Blood Loss, Postoperative, Blood Loss, Surgical
Multan, Punjab Province, Pakistan
View Trial Details